ReviewArab journal of urology2015

Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review.

Albert Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.